Related Experiment Video

Updated: Apr 1, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.4K

The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia

Alexandra McFarlane1, Wendy Sligl2

  • 1Division of Infectious Diseases, Faculty of Medicine and Dentistry, University of Alberta, 1-124 Clinical Sciences Building, 8440 112 Street, Edmonton, AB, T6G 2B7, Canada. amcfarla@ualberta.ca.

Current Infectious Disease Reports
|October 9, 2015
PubMed

Insights

Macrolide antibiotics, used for respiratory infections, show immune-modulating benefits beyond antimicrobial action. This review examines their efficacy, mechanisms, and side effects in pneumonia patients, offering treatment recommendations.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Immunology

Background:

  • Macrolide antimicrobials are frequently prescribed for respiratory tract infections.
  • Widespread macrolide resistance is limiting their effectiveness.
  • Macrolides possess immune-modulatory properties with potential survival benefits in inflammatory conditions.

Purpose of the Study:

  • To review the efficacy, mechanisms, and adverse effects of macrolide therapy in community-acquired pneumonia (CAP).
  • To discuss challenges in macrolide research and offer treatment recommendations.

Main Methods:

  • Literature review focusing on macrolide therapy in CAP.
  • Analysis of antimicrobial and immune-modulatory effects.
  • Evaluation of outcomes across different patient settings (outpatient, inpatient, ICU).

Main Results:

  • Macrolides exhibit both antimicrobial and significant immune-modulatory effects in CAP.
  • Benefits may extend beyond direct bacterial killing, influencing inflammatory responses.
  • Adverse effects and resistance patterns are critical considerations.

Conclusions:

  • Macrolide therapy for CAP warrants consideration for its immune-modulatory properties, alongside antimicrobial action.
  • Further research is needed to optimize macrolide use in light of resistance and varied clinical benefits.
  • Evidence-based treatment recommendations are provided for different CAP severity levels.
Keywords:
Community-acquired pneumoniaMacrolide antimicrobialsMacrolide-based regimensRespiratory tract infections

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.9K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
41
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
664
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.2K